FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine and concerns preparing a fast-acting effective and safe agent for treating rhinitis. Solving the problem provides the agent for treating rhinitis, particularly allergi rhinitis containing C-type natriuretic peptide (CNP) and/or B-type natriuretic peptide (BNP) as an active ingredient.
EFFECT: invention provides the notable health improvement in rhinitis, particularly in allergic rhinitis, and besides, the therapeutic effect, ensures fast and prolonged action, and gives no local side effects.
21 cl, 7 ex, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION OF DERMAL MEDICATION FOR EXTERNAL APPLICATION | 2010 |
|
RU2572694C2 |
| TREATMENT OF ALLERGIC RHINITIS IN PEDIATRIC CATEGORY USING A COMBINATION OF MOMETASONE AND OLOPATADINE | 2019 |
|
RU2798030C2 |
| COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS | 2013 |
|
RU2652352C2 |
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
| TREATMENT OF ALLERGIC RHINITIS USING COMBINATION OF MOMETASONE AND OLOPATADINE | 2014 |
|
RU2686670C2 |
| NOVEL NRP-B AGONISTS | 2010 |
|
RU2557290C2 |
| NEW NPR-B AGONISTS | 2010 |
|
RU2636738C2 |
| METHOD FOR TREATING PATIENTS WITH ALLERGIC RHINITIS ASSOCIATED WITH CHRONIC RHINOSINUSITIS OF BACTERIAL ETIOLOGY USING A DOMESTICALLY PRODUCED TOPICAL IMMUNE CORRECTOR | 2020 |
|
RU2760825C1 |
| COMPOSITIONS OF NONSTEROID ANTI-INFLAMMATORY DRUGS, ANTICONGESTIVE AGENTS AND ANTIHISTAMINICS | 2003 |
|
RU2322262C2 |
| METHOD FOR TREATING PATIENTS SUFFERING FROM ALLERGIC RHINITIS | 2008 |
|
RU2373968C1 |
